SEC Form 4 · accession 0001140361-17-025714
Health Insurance Innovations, Inc. · HIIQ
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Sheldon Wang
Officer — Chief Technology Officer · Director
Period of report
Jun 14, 2017
Accepted (ET)
Jun 21, 2017 · 5:25 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001561387
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Class A Common Stock | Jun 14, 2017 | M | 23,826 | $6.77 | A | 262,577 | D | |
| Class A Common StockF1 | Jun 14, 2017 | D | 2,319 | $21.90 | D | 260,258 | D | |
| Class A Common StockF1 | Jun 14, 2017 | D | 751 | $22.20 | D | 259,507 | D | |
| Class A Common StockF1 | Jun 14, 2017 | D | 2,330 | $21.80 | D | 257,177 | D | |
| Class A Common StockF1 | Jun 14, 2017 | D | 2,005 | $21.50 | D | 255,172 | D | |
| Class A Common StockF2 | Jun 14, 2017 | S | 16,421 | $21.7936 | D | 238,751 | D | |
| Class A Common Stock | Jun 19, 2017 | S | 10,000 | $24.95 | D | 228,751 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Appreciation RightsF4 | $6.77 | Jun 14, 2017 | M | 23,826 | D | — | May 25, 2021 | Class A Common Stock | 23,826 | 41,039 | D |
| Stock Appreciation RightsF5 | $12.13 | holding | — | — | — | — | Jul 14, 2021 | Class A Common Stock | 6,000 | 6,000 | D |
| Stock Appreciation RightsF6 | $4.95 | holding | — | — | — | — | Jul 1, 2022 | Class A Common Stock | 30,000 | 30,000 | D |
Explanation of responses
- F1Shares retained by the issuer to satisfy the exercise price of stock appreciation rights exercised by the reporting person.
- F2The price in Column 4 is a weighted average price. The prices actually received ranged from $21.50 to $22.20. The reporting person has provided to the issuer, and will provide to any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range for all transactions reported in this Form 4 utilizing a weighted average price.
- F3These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person in November, 2016.
- F4These stock-settled stock appreciation rights were granted under the Issuer's Long Term Incentive Plan (the "Plan") and are vested as of the date of this Form 4.
- F5These stock-settled stock appreciation rights were previously granted under the Plan and are scheduled to vest in increments of 20%, 20%, 20%, and 40% on successive anniversary dates of the grant, subject to the terms of the plan and an award agreement under the plan.
- F6These stock-settled stock appreciation rights were previously granted under the Plan and are scheduled to vest in increments of 25%, 25%, and 50% on successive anniversary dates of the grant, subject to the terms of the Plan and an award agreement under the Plan.